BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16343216)

  • 1. Report of an unusual problematic uterine smooth muscle neoplasm, emphasizing the prognostic importance of coagulative tumor cell necrosis.
    Amant F; Moerman P; Vergote I
    Int J Gynecol Cancer; 2005; 15(6):1210-2. PubMed ID: 16343216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases.
    Bell SW; Kempson RL; Hendrickson MR
    Am J Surg Pathol; 1994 Jun; 18(6):535-58. PubMed ID: 8179071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stanford parameters stratify the risk of recurrence in gynecologic smooth muscle tumors of uncertain malignant potential.
    Travaglino A; Raffone A; Gencarelli A; Caldarelli C; Granata M; Santoro A; Zannoni GF; Mollo A; Zullo F; Insabato L
    APMIS; 2021 Jun; 129(6):283-290. PubMed ID: 33786917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
    Ip PP; Cheung AN; Clement PB
    Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reappraisal of the pathological criteria for uterine leiomyosarcoma].
    Guo L; Liu T; Huang H
    Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):266-9. PubMed ID: 9388868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine smooth muscle tumor of uncertain malignant potential: a three-case report.
    Berretta R; Rolla M; Merisio C; Giordano G; Nardelli GB
    Int J Gynecol Cancer; 2008; 18(5):1121-6. PubMed ID: 17986240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic considerations of uterine smooth muscle tumors.
    Prayson RA; Hart WR
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases with a comparison to retroperitoneal leiomyosarcomas.
    Paal E; Miettinen M
    Am J Surg Pathol; 2001 Nov; 25(11):1355-63. PubMed ID: 11684951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
    Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
    Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Border-line smooth-muscle tumor of the uterus: analysis of 131 patients].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):698-700. PubMed ID: 16438896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual types of smooth muscle tumors of uterine corpus: case reports and literature review.
    Makharoblidze E; Goishvili N; Mchedlishvili M; Khakhutaishvili I; Jangavadze M
    Georgian Med News; 2013 Mar; (216):7-11. PubMed ID: 23567300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine smooth-muscle tumor of uncertain malignant potential metastasizing to the humerus as a high-grade leiomyosarcoma.
    Shapiro A; Ferenczy A; Turcotte R; Bruchim I; Gotlieb WH
    Gynecol Oncol; 2004 Sep; 94(3):818-20. PubMed ID: 15350379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine smooth-muscle tumors of uncertain malignant potential.
    Peters WA; Howard DR; Andersen WA; Figge DC
    Obstet Gynecol; 1994 Jun; 83(6):1015-20. PubMed ID: 8190416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.
    Ünver NU; Acikalin MF; Öner Ü; Ciftci E; Ozalp SS; Colak E
    Arch Gynecol Obstet; 2011 Aug; 284(2):483-90. PubMed ID: 20878171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical intradermal smooth muscle neoplasms: clinicopathologic analysis of 84 cases and a reappraisal of cutaneous "leiomyosarcoma".
    Kraft S; Fletcher CD
    Am J Surg Pathol; 2011 Apr; 35(4):599-607. PubMed ID: 21358302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine smooth muscle tumor of uncertain malignant potential: fertility and clinical outcomes.
    Şahin H; Karatas F; Coban G; Özen Ö; Erdem Ö; Onan MA; Ayhan A
    J Gynecol Oncol; 2019 Jul; 30(4):e54. PubMed ID: 31074239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine smooth muscle tumors of uncertain malignant potential: a case presentation.
    Gezginç K; Yazici F; Tavli L
    Int J Clin Oncol; 2011 Oct; 16(5):592-5. PubMed ID: 21225306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence.
    Dall'Asta A; Gizzo S; Musarò A; Quaranta M; Noventa M; Migliavacca C; Sozzi G; Monica M; Mautone D; Berretta R
    Int J Clin Exp Pathol; 2014; 7(11):8136-42. PubMed ID: 25550862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: a pathologic analysis of 100 cases.
    Ranchod M; Kempson RL
    Cancer; 1977 Jan; 39(1):255-62. PubMed ID: 832238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smooth muscle tumors of the uterus: a practical approach.
    Toledo G; Oliva E
    Arch Pathol Lab Med; 2008 Apr; 132(4):595-605. PubMed ID: 18384211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.